Switzerland

There is a confidentiality arrangement in place between the European Medicines Agency (EMA), the European Commission's Directorate General for Health and Food Safety (DG SANTE), the Swiss Agency for Therapeutic Products (Swissmedic) and the Swiss Federal Department of Home Affairs (FDHA) since 10 July 2015.

The agreement covers non-public information on the safety, quality and efficacy of medicines, already authorised or under review, both in Switzerland and in the European Union (EU) in order to enhance public health protection.

The arrangement supports efforts by European and Swiss regulators to improve the oversight of medicines for human and animal health. It is valid for five years and may be renewed.